 | • レポートコード：MRC2312MG11703 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の体重管理薬市場規模と予測を収録しています。・世界の体重管理薬市場：売上、2018年-2023年、2024年-2029年 ・世界の体重管理薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の体重管理薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カプセル型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 体重管理薬のグローバル主要企業は、Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcareなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、体重管理薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の体重管理薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の体重管理薬市場：タイプ別市場シェア、2022年 ・カプセル型、フレーク型 世界の体重管理薬市場：用途別、2018年-2023年、2024年-2029年 世界の体重管理薬市場：用途別市場シェア、2022年 ・子供、成人 世界の体重管理薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の体重管理薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における体重管理薬のグローバル売上、2018年-2023年 ・主要企業における体重管理薬のグローバル売上シェア、2022年 ・主要企業における体重管理薬のグローバル販売量、2018年-2023年 ・主要企業における体重管理薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcare ************************************************************* ・調査・分析レポートの概要 体重管理薬市場の定義 市場セグメント 世界の体重管理薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の体重管理薬市場規模 世界の体重管理薬市場規模：2022年 VS 2029年 世界の体重管理薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの体重管理薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の体重管理薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：カプセル型、フレーク型 体重管理薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：子供、成人 体重管理薬の用途別グローバル売上・予測 ・地域別市場分析 地域別体重管理薬市場規模 2022年と2029年 地域別体重管理薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Versanis、 Rivus Pharmaceuticals、 Spitfire Pharma、 GSK、 Altimmune、 Currax Pharmaceuticals、 Wanbang Pharmaceutical Technology、 Highfine Biotech、 Keyuan Pharmaceutical、 BrightGene Bio-Medical Technology、 Sinopep-Allsino Bio Pharmaceutical、 Dezhan Healthcare ... |
This research report provides a comprehensive analysis of the Weight Control Medication market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Weight Control Medication market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Weight Control Medication, challenges faced by the industry, and potential opportunities for market players.
The global Weight Control Medication market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Weight Control Medication market presents opportunities for various stakeholders, including Child, Aldult. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Weight Control Medication market. Additionally, the growing consumer demand present avenues for market expansion.
The global Weight Control Medication market was valued at US$ 1277.1 million in 2022 and is projected to reach US$ 2626.7 million by 2029, at a CAGR of 10.9% during the forecast period.
Weight management medications are medications used to help people manage their weight, lose weight, or treat obesity. Developments and trends in these drugs are constantly changing to reflect scientific research, medical needs, and social trends. As genetics and gene sequencing technologies advance, a future trend may be to better match weight management drugs to an individual’s genotype and metabolotype to achieve better personalized treatment results. It is expected that more weight management drug combinations will emerge to take advantage of the complementary effects of different drugs to improve the effectiveness of weight management.
Key Features:
The research report on the Weight Control Medication market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Weight Control Medication market.
Market Overview: The report provides a comprehensive overview of the Weight Control Medication market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Capsule Type, Flaky Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Weight Control Medication market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Weight Control Medication market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Weight Control Medication market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Weight Control Medication market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Weight Control Medication market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Weight Control Medication market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Weight Control Medication, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Weight Control Medication market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Weight Control Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Capsule Type
Flaky Type
Market segment by Application
Child
Aldult
Global Weight Control Medication Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Versanis
Rivus Pharmaceuticals
Spitfire Pharma
GSK
Altimmune
Currax Pharmaceuticals
Wanbang Pharmaceutical Technology
Highfine Biotech
Keyuan Pharmaceutical
BrightGene Bio-Medical Technology
Sinopep-Allsino Bio Pharmaceutical
Dezhan Healthcare
Outline of Major Chapters:
Chapter 1: Introduces the definition of Weight Control Medication, market overview.
Chapter 2: Global Weight Control Medication market size in revenue.
Chapter 3: Detailed analysis of Weight Control Medication company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Weight Control Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Weight Control Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Weight Control Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Weight Control Medication Overall Market Size
2.1 Global Weight Control Medication Market Size: 2022 VS 2029
2.2 Global Weight Control Medication Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Weight Control Medication Players in Global Market
3.2 Top Global Weight Control Medication Companies Ranked by Revenue
3.3 Global Weight Control Medication Revenue by Companies
3.4 Top 3 and Top 5 Weight Control Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Weight Control Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Weight Control Medication Players in Global Market
3.6.1 List of Global Tier 1 Weight Control Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Weight Control Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Weight Control Medication Market Size Markets, 2022 & 2029
4.1.2 Capsule Type
4.1.3 Flaky Type
4.2 By Type – Global Weight Control Medication Revenue & Forecasts
4.2.1 By Type – Global Weight Control Medication Revenue, 2018-2023
4.2.2 By Type – Global Weight Control Medication Revenue, 2024-2029
4.2.3 By Type – Global Weight Control Medication Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Weight Control Medication Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Aldult
5.2 By Application – Global Weight Control Medication Revenue & Forecasts
5.2.1 By Application – Global Weight Control Medication Revenue, 2018-2023
5.2.2 By Application – Global Weight Control Medication Revenue, 2024-2029
5.2.3 By Application – Global Weight Control Medication Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Weight Control Medication Market Size, 2022 & 2029
6.2 By Region – Global Weight Control Medication Revenue & Forecasts
6.2.1 By Region – Global Weight Control Medication Revenue, 2018-2023
6.2.2 By Region – Global Weight Control Medication Revenue, 2024-2029
6.2.3 By Region – Global Weight Control Medication Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Weight Control Medication Revenue, 2018-2029
6.3.2 US Weight Control Medication Market Size, 2018-2029
6.3.3 Canada Weight Control Medication Market Size, 2018-2029
6.3.4 Mexico Weight Control Medication Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Weight Control Medication Revenue, 2018-2029
6.4.2 Germany Weight Control Medication Market Size, 2018-2029
6.4.3 France Weight Control Medication Market Size, 2018-2029
6.4.4 U.K. Weight Control Medication Market Size, 2018-2029
6.4.5 Italy Weight Control Medication Market Size, 2018-2029
6.4.6 Russia Weight Control Medication Market Size, 2018-2029
6.4.7 Nordic Countries Weight Control Medication Market Size, 2018-2029
6.4.8 Benelux Weight Control Medication Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Weight Control Medication Revenue, 2018-2029
6.5.2 China Weight Control Medication Market Size, 2018-2029
6.5.3 Japan Weight Control Medication Market Size, 2018-2029
6.5.4 South Korea Weight Control Medication Market Size, 2018-2029
6.5.5 Southeast Asia Weight Control Medication Market Size, 2018-2029
6.5.6 India Weight Control Medication Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Weight Control Medication Revenue, 2018-2029
6.6.2 Brazil Weight Control Medication Market Size, 2018-2029
6.6.3 Argentina Weight Control Medication Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Weight Control Medication Revenue, 2018-2029
6.7.2 Turkey Weight Control Medication Market Size, 2018-2029
6.7.3 Israel Weight Control Medication Market Size, 2018-2029
6.7.4 Saudi Arabia Weight Control Medication Market Size, 2018-2029
6.7.5 UAE Weight Control Medication Market Size, 2018-2029
7 Weight Control Medication Companies Profiles
7.1 Versanis
7.1.1 Versanis Company Summary
7.1.2 Versanis Business Overview
7.1.3 Versanis Weight Control Medication Major Product Offerings
7.1.4 Versanis Weight Control Medication Revenue in Global Market (2018-2023)
7.1.5 Versanis Key News & Latest Developments
7.2 Rivus Pharmaceuticals
7.2.1 Rivus Pharmaceuticals Company Summary
7.2.2 Rivus Pharmaceuticals Business Overview
7.2.3 Rivus Pharmaceuticals Weight Control Medication Major Product Offerings
7.2.4 Rivus Pharmaceuticals Weight Control Medication Revenue in Global Market (2018-2023)
7.2.5 Rivus Pharmaceuticals Key News & Latest Developments
7.3 Spitfire Pharma
7.3.1 Spitfire Pharma Company Summary
7.3.2 Spitfire Pharma Business Overview
7.3.3 Spitfire Pharma Weight Control Medication Major Product Offerings
7.3.4 Spitfire Pharma Weight Control Medication Revenue in Global Market (2018-2023)
7.3.5 Spitfire Pharma Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Weight Control Medication Major Product Offerings
7.4.4 GSK Weight Control Medication Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Altimmune
7.5.1 Altimmune Company Summary
7.5.2 Altimmune Business Overview
7.5.3 Altimmune Weight Control Medication Major Product Offerings
7.5.4 Altimmune Weight Control Medication Revenue in Global Market (2018-2023)
7.5.5 Altimmune Key News & Latest Developments
7.6 Currax Pharmaceuticals
7.6.1 Currax Pharmaceuticals Company Summary
7.6.2 Currax Pharmaceuticals Business Overview
7.6.3 Currax Pharmaceuticals Weight Control Medication Major Product Offerings
7.6.4 Currax Pharmaceuticals Weight Control Medication Revenue in Global Market (2018-2023)
7.6.5 Currax Pharmaceuticals Key News & Latest Developments
7.7 Wanbang Pharmaceutical Technology
7.7.1 Wanbang Pharmaceutical Technology Company Summary
7.7.2 Wanbang Pharmaceutical Technology Business Overview
7.7.3 Wanbang Pharmaceutical Technology Weight Control Medication Major Product Offerings
7.7.4 Wanbang Pharmaceutical Technology Weight Control Medication Revenue in Global Market (2018-2023)
7.7.5 Wanbang Pharmaceutical Technology Key News & Latest Developments
7.8 Highfine Biotech
7.8.1 Highfine Biotech Company Summary
7.8.2 Highfine Biotech Business Overview
7.8.3 Highfine Biotech Weight Control Medication Major Product Offerings
7.8.4 Highfine Biotech Weight Control Medication Revenue in Global Market (2018-2023)
7.8.5 Highfine Biotech Key News & Latest Developments
7.9 Keyuan Pharmaceutical
7.9.1 Keyuan Pharmaceutical Company Summary
7.9.2 Keyuan Pharmaceutical Business Overview
7.9.3 Keyuan Pharmaceutical Weight Control Medication Major Product Offerings
7.9.4 Keyuan Pharmaceutical Weight Control Medication Revenue in Global Market (2018-2023)
7.9.5 Keyuan Pharmaceutical Key News & Latest Developments
7.10 BrightGene Bio-Medical Technology
7.10.1 BrightGene Bio-Medical Technology Company Summary
7.10.2 BrightGene Bio-Medical Technology Business Overview
7.10.3 BrightGene Bio-Medical Technology Weight Control Medication Major Product Offerings
7.10.4 BrightGene Bio-Medical Technology Weight Control Medication Revenue in Global Market (2018-2023)
7.10.5 BrightGene Bio-Medical Technology Key News & Latest Developments
7.11 Sinopep-Allsino Bio Pharmaceutical
7.11.1 Sinopep-Allsino Bio Pharmaceutical Company Summary
7.11.2 Sinopep-Allsino Bio Pharmaceutical Business Overview
7.11.3 Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Major Product Offerings
7.11.4 Sinopep-Allsino Bio Pharmaceutical Weight Control Medication Revenue in Global Market (2018-2023)
7.11.5 Sinopep-Allsino Bio Pharmaceutical Key News & Latest Developments
7.12 Dezhan Healthcare
7.12.1 Dezhan Healthcare Company Summary
7.12.2 Dezhan Healthcare Business Overview
7.12.3 Dezhan Healthcare Weight Control Medication Major Product Offerings
7.12.4 Dezhan Healthcare Weight Control Medication Revenue in Global Market (2018-2023)
7.12.5 Dezhan Healthcare Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
